FOLR1 and ovarian carcinoma: Pellegrino focused on her recent progress in use of cubic-shaped iron oxide magnetic nanoparticles as a delivery tool for heat-mediated drug delivery (i.e., synthesis, functionalization, characterization, and drug loading) and in vitro and in vivo (both subcutaneous and orthotopic models) studies with targeting magnetic nanoparticles to FRα-overexpressing ovarian cancer cells with anti-FRα antibody fragments [30].